Scholarly Index
Natasha de Peyrecave
UCB Pharma (Belgium); 673 total citations; 59 total publications; best world rank #1,000
UCB Pharma (Belgium)
673Total citations
59Total publications
10H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Spondyloarthritis Studies and Treatments | 2021-2025 | 1,000 | BE 16 | 76.43 |